Friday, January 23, 2026

CATEGORY

General

Cancer Therapy Breakthrough with Claudin 18.2-Targeted Drug Approved in EU

Key TakeawaysClaudin 18.2-positive gastric/GEJ cancer. Vyloy demonstrated significant survival benefits in pivotal trials. Sales could exceed $1 billion, pending widespread adoption of Claudin...

Therapy Milestone: Yipurun’s Drug-Device Combination Secures Approval in China

Key Takeaways:Therapy for moderate-to-severe intrauterine adhesions (IUA) has advanced with the approval of Yipurun's Corina Intrauterine Drug-Eluting System in China. The Corina system...

Bone Marrow Aspiration Advances: SurGenTec’s B-MAN Kit Receives FDA 510(k) Clearance

Key Takeaways:Bone marrow aspiration is simplified with SurGenTec’s B-MAN Kit, which features an integrated filtration system that eliminates the need for a centrifuge. ...

Knee Cartilage Repair: FDA Approves Arthroscopic Delivery of Vericel’s MACI for Knee Cartilage Defects

Key Takeaways:Knee cartilage defects can now be treated less invasively with the FDA-approved arthroscopic delivery of Vericel’s MACI, using the patient’s own cultured...

How Large Language Models and Generative AI Are Transforming MedTech Design

The rapid advancement of artificial intelligence (AI), particularly large language models (LLMs) and generative AI, is reshaping the landscape of medical device design and...

PTSD Treatment Access Expands: GrayMatters Health Brings FDA-Cleared Prism for PTSDâ„¢ to Veterans and Civilians

PTSD is a debilitating mental health condition that affects approximately 13 million Americans, often developing after traumatic events such as combat, assault, abuse, accidents,...

New Service Packages for Special and Incurable Disease Patients in Iran

The Iranian Health Insurance Organization has unveiled new service packages aimed at enhancing the support provided to patients suffering from special and incurable diseases....

Aldeyra’s Reproxalap Achieves Milestone in Phase 3 Dry Eye Disease Trial

Aldeyra Therapeutics, a pioneering biotechnology company focused on developing innovative therapies for immune-mediated and metabolic diseases, has achieved a significant milestone with its investigational...

Join Us for the 2nd Annual ACCESS EU Conference in Barcelona, Spain!

Addressing Challenges Impacting Patient Access Market Access Today is proud to be a media partner of the 2nd annual ACCESS EU conference.Details will be published...

PARP Inhibitors Poised to Revolutionize Cancer Treatment: InsightAce Analytic Market Report

InsightAce Analytic Pvt. Ltd. has announced the release of a comprehensive market assessment report titled "Global PARP Inhibitors Market Size, Share & Trends Analysis...

Pharmaceuticals Collaboration Deals Report 2019-2024: Payments, Therapy Focus, and Technology

Pharmaceutical collaboration deals are thoroughly examined in the "Collaboration Deals in Pharmaceuticals" report, which provides a detailed understanding and analysis of the nature, structure,...

Patient-Centered Outcomes in Healthcare: Measurement and Impact from Market Access Perspective

10 Key Takeaways from Patient-Centered Outcomes in HealthcareDefinition and Importance: Patient-centered outcomes focus on measures that reflect patients' perspectives on their health, quality...

The Possible Impact of Digital Twins on Market Access Through Clinical Trials

Key Takeaways from The Possible Impact of Digital Twins on Market Access Through Clinical TrialsIntroduction to Digital Twins: Digital twins, initially developed in...

The Market Access of Supplements in Europe

Key Takeaways from the Market Access of Supplements in Europe:Evolving Market Dynamics: The market access for dietary supplements in Europe has undergone significant...

Top 10 Market Access & HEOR Trends for 2024 and Beyond

Key Takeaways from the Article on Top 10 Market Access Trends and HEOR TrendsReal-World Evidence (RWE): Vital for understanding patient outcomes beyond clinical...

Latest news